Annotation Detail for ANKRD6

Basic Information
Top
Pathway ID | Pathway Name |
---|
P00057 | Wnt signaling pathway |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C028474 |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene affects the expression of ANKRD6 mRNA | affects expression | 18281256
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of ANKRD6 mRNA | decreases expression | 20064835
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of ANKRD6 mRNA | increases expression | 15336504
|
C009131 |
pyrimidin-2-one beta-ribofuranoside |
pyrimidin-2-one beta-ribofuranoside results in decreased expression of ANKRD6 mRNA | decreases expression | 19194470
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of ANKRD6 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
4.02 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.30 | 19490988 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.05 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.84 | 6695378 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.85 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.86 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.56 | 19183758 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.98 | 19232924 17688650 20603192 17157402 15238991 17507914 18775368 18316065 18177632 18985861 19460635 18558336 18396377 16609825 18940202 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.23 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.61 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.00 | 20146248 17474063 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.13 | 20419170 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.81 | 20734317 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 8888407 17688650 16575769 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.25 | 19641884 1733752 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.45 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.64 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.53 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.09 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.91 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.78 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.60 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.07 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.67 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.50 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.57 | 18558336 8888407 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.82 | 20471113 |
MESH:D006529 |
Hepatomegaly |
|
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
5.24 | 16109766 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.41 | 17688650 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.19 | 17596541 16294345 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
2.14 | 21137059 20195826 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.87 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
1.57 | 18816296 20869020 18569708 20064080 20464547 17053015 18520028 6695378 20135361 |
MESH:D008545 |
Melanoma |
|
pyrimidin-2-one beta-ribofuranoside |
3.78 | 16505122 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.44 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.46 | 16381670 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.40 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.33 | 17596541 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.31 | 11141357 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.34 | 8888407 16359493 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.37 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.91 | 17292933 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.15 | 11422049 12752131 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.58 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.10 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.96 | 15475178 14763951 17978042 1511512 16876388 11738929 3137016 11044598 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
6.19 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
6.19 | 8532709 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.06 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.15 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.85 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
5.06 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.29 | 17053015 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.13 | 8888407 |